Accenture vs Genpact: Which Stock Offers More Value?

Home > Comparison > Technology > ACN vs G

The strategic rivalry between Accenture plc and Genpact Limited defines the current trajectory of the Technology sector. Accenture operates as a global professional services powerhouse with a broad portfolio spanning consulting, technology, and operations. Genpact, by contrast, focuses on business process outsourcing and IT services with a strong presence in financial and operational domains. This analysis aims to identify which company’s operational model offers a superior risk-adjusted return for a diversified portfolio.

Table of contents

• Companies Overview
• Income Statement Comparison
• Financial Ratios Comparison
• How are the two companies positioned?
• Which stock offers better returns?
• How do institutions grade them?
• Risks specific to each company
• Final Verdict: Which stock to choose?

Companies Overview

Accenture and Genpact stand as pivotal players in the global Information Technology Services sector, influencing digital transformation and outsourcing markets.

Accenture plc: Global Digital Transformation Leader

Accenture dominates as a professional services powerhouse, generating revenue through strategy, consulting, and technology integration. Its competitive advantage lies in agile transformation, intelligent automation, and cloud services. In 2026, Accenture sharpens its focus on advanced AI, cybersecurity, and sustainable digital innovation to maintain industry leadership.

Genpact Limited: Specialist in Business Process Outsourcing

Genpact excels in business process outsourcing and IT services across multiple industries including banking and healthcare. Its core revenue stems from finance, supply chain, and transformation services. In 2026, Genpact emphasizes ESG solutions, digital analytics, and finance advisory to deepen client engagement and operational efficiency.

Strategic Collision: Similarities & Divergences

Both firms prioritize digital services but diverge in business philosophy: Accenture offers a broad technology ecosystem while Genpact zeroes in on process outsourcing and niche consulting. Their primary battleground is enterprise digital transformation, where Accenture leads in scale and innovation, and Genpact focuses on specialized operational excellence. These distinctions shape contrasting investment profiles: Accenture as a diversified tech leader, Genpact as a focused outsourcing specialist.

Income Statement Comparison

This data dissects the core profitability and scalability of both corporate engines to reveal who dominates the bottom line:

Metric	Accenture plc (ACN)	Genpact Limited (G)
Revenue	69.7B	5.1B
Cost of Revenue	47.4B	3.2B
Operating Expenses	12.0B	1.0B
Gross Profit	22.2B	1.8B
EBITDA	12.9B	875M
EBIT	10.5B	780M
Interest Expense	229M	50M
Net Income	7.7B	552M
EPS	12.29	3.18
Fiscal Year	2025	2025

Income Statement Analysis: The Bottom-Line Duel

This income statement comparison exposes which company converts revenue into profit most efficiently, revealing the strength of their business engines.

Accenture plc Analysis

Accenture’s revenue climbed steadily from $50.5B in 2021 to $69.7B in 2025, reflecting a 38% growth over five years. Net income rose nearly 30% to $7.7B by 2025. Gross margin remains robust near 32%, supporting a healthy net margin around 11%. The latest year shows solid momentum with operating expenses well-controlled and EBIT growing 7.6%, signaling operational efficiency.

Genpact Limited Analysis

Genpact increased revenue from $4.0B in 2021 to $5.1B in 2025, a 26% gain over the period. Net income surged 50% to $552M, showing strong bottom-line leverage. Gross margin improved to 36%, slightly outpacing Accenture, while net margin holds near 11%. The latest year’s moderate EBIT growth of 3.1% and EPS rise of nearly 10% indicate steady profitability expansion.

Margin Strength vs. Growth Scale

Accenture outpaces Genpact in absolute revenue and net income scale, delivering consistent margin quality and stronger EBIT growth. Genpact boasts higher margin percentages and faster net income growth but from a smaller base. For investors, Accenture’s scale and efficiency suit those favoring stability, while Genpact appeals to those seeking sharper margin expansion and earnings momentum.

Financial Ratios Comparison

These vital ratios act as a diagnostic tool to expose the underlying fiscal health, valuation premiums, and capital efficiency of the companies compared below:

Ratios	Accenture plc (ACN)	Genpact Limited (G)
ROE	24.6%	21.7%
ROIC	17.0%	12.3%
P/E	21.2	14.7
P/B	5.21	3.19
Current Ratio	1.42	1.66
Quick Ratio	1.42	1.66
D/E (Debt-to-Equity)	0.26	0.23
Debt-to-Assets	12.5%	9.9%
Interest Coverage	44.7	15.3
Asset Turnover	1.07	0.87
Fixed Asset Turnover	16.2	13.6
Payout Ratio	48.2%	21.3%
Dividend Yield	2.28%	1.45%
Fiscal Year	2025	2025

Efficiency & Valuation Duel: The Vital Signs

Ratios act like a company’s DNA, revealing hidden risks and operational strengths that define its market standing and shareholder value.

Accenture plc

Accenture delivers strong profitability with a 24.6% ROE and an 11.0% net margin, signaling operational excellence. Its P/E of 21.2 is neutral, suggesting fair valuation amid robust returns. The stock offers a solid 2.3% dividend yield, reflecting balanced capital allocation between rewarding shareholders and reinvesting in growth.

Genpact Limited

Genpact posts a decent 21.7% ROE and a 10.9% net margin, showing efficient operations at a leaner scale. With a P/E of 14.7, the stock appears attractively valued. Dividend yield stands modest at 1.5%, indicating some shareholder return alongside focused reinvestment to sustain its favorable 12.3% ROIC.

Balanced Profitability vs. Value Appeal

Accenture excels in profitability and shareholder returns but trades at a higher multiple. Genpact offers a more attractive valuation with slightly lower returns. Investors seeking operational strength may lean toward Accenture, while value-focused investors might prefer Genpact’s favorable price metrics.

Which one offers the Superior Shareholder Reward?

I observe Accenture plc (ACN) delivers a 2.28% dividend yield with a 48% payout ratio, backed by strong free cash flow coverage (2.67x). Its buybacks are aggressive, enhancing total returns sustainably. Genpact Limited (G) yields 1.45% with a 21% payout ratio, reflecting a conservative distribution and modest buybacks. Genpact’s lower payout supports reinvestment, but weaker free cash flow coverage (4.15x dividend+capex) and higher debt raise concerns. Historically in consulting, consistent dividends plus robust buybacks like ACN’s generate superior shareholder rewards. I conclude ACN offers a more attractive and sustainable total return profile in 2026.

Comparative Score Analysis: The Strategic Profile

The radar chart reveals the fundamental DNA and trade-offs of Accenture plc and Genpact Limited, highlighting their strategic financial strengths and vulnerabilities:

Accenture excels in return on equity (5) and assets (5), reflecting superior operational efficiency. Genpact leads in discounted cash flow (5) and holds a moderate valuation edge with a better P/E score (3). Both share weak debt-to-equity scores (2), signaling balance sheet leverage concerns. Accenture’s profile is more skewed towards profitability metrics, while Genpact shows a slightly more balanced valuation and cash flow stance.

Bankruptcy Risk: Solvency Showdown

Accenture’s Altman Z-Score (5.29) surpasses Genpact’s (3.09), both securely in the safe zone. This gap underscores Accenture’s stronger buffer against financial distress in volatile cycles:

Financial Health: Quality of Operations

Genpact’s Piotroski F-Score of 8 indicates robust financial health, outperforming Accenture’s average score of 6. This suggests Genpact maintains stronger internal metrics and fewer red flags:

How are the two companies positioned?

This section dissects ACN and G’s operational DNA by comparing their revenue distribution and internal strengths and weaknesses. The goal is to confront their economic moats to reveal which model delivers the most resilient competitive advantage in today’s market.

Revenue Segmentation: The Strategic Mix

This comparison dissects how Accenture plc and Genpact Limited diversify their income streams and highlights their primary sector bets:

Accenture pivots on two massive segments: Consulting at $35.1B and Outsourcing near $34.6B, reflecting a balanced dual-engine model. Genpact, in contrast, relies heavily on Consumer and Healthcare at $1.7B, showing less diversification. Accenture’s wide sector coverage anchors its ecosystem lock-in and infrastructure dominance. Genpact’s concentration in a niche exposes it to sector-specific risks but allows focused specialization.

Strengths and Weaknesses Comparison

This table compares the strengths and weaknesses of Accenture plc and Genpact Limited:

Both companies show solid profitability and financial health. Accenture’s diversification and global scale contrast with Genpact’s focused model and cost efficiency. Each faces distinct valuation and operational trade-offs impacting their strategic positioning.

The Moat Duel: Analyzing Competitive Defensibility

A structural moat is the only true shield protecting long-term profits from relentless competition erosion. Let’s dissect the defenses of two industry players:

Accenture plc: Diversified Expertise and Scale Moat

Accenture’s moat stems from its broad consulting expertise and global scale, delivering stable 15% EBIT margins. Its declining ROIC trend signals margin pressure but new digital services may reinforce resilience in 2026.

Genpact Limited: Process Excellence and Growth Moat

Genpact leverages process specialization and evolving digital capabilities, maintaining a slightly higher EBIT margin than Accenture. Its rising ROIC trend and strong margin growth position it well for expansion in emerging markets.

Verdict: Scale and Expertise vs. Process Innovation

Accenture holds a wider moat with vast scale and diversified service lines, but its eroding ROIC warns of margin challenges. Genpact’s sharper ROIC improvement gives it a deeper moat trajectory. I see Genpact better equipped to sustain and grow market share in 2026.

Which stock offers better returns?

The past year shows contrasting price dynamics: Accenture’s stock fell sharply, while Genpact posted a solid gain with slowing momentum in recent months.

Trend Comparison

Accenture’s stock declined 35.77% over the past year, marking a bearish trend with accelerating losses and high volatility. It hit a high of 388.0 and a low of 238.39.

Genpact’s stock rose 21.95%, reflecting a bullish trend with decelerating growth and low volatility. It reached a high of 55.05 and a low of 30.9 during this period.

Genpact outperformed Accenture significantly, delivering positive market returns versus Accenture’s substantial decline over the last 12 months.

Target Prices

Analysts present a confident upward target consensus for both Accenture plc and Genpact Limited.

Company	Target Low	Target High	Consensus
Accenture plc	265	330	302.93
Genpact Limited	42	50	46

Accenture’s target consensus at $303 significantly exceeds its current price of $241, signaling strong growth expectations. Genpact’s consensus of $46 also comfortably surpasses its $40 current price, indicating moderate upside potential.

How do institutions grade them?

Accenture plc Grades

The following table summarizes recent institutional grades for Accenture plc:

Grading Company	Action	New Grade	Date
Wells Fargo	Maintain	Equal Weight	2026-01-14
UBS	Maintain	Buy	2025-12-19
RBC Capital	Maintain	Outperform	2025-12-19
Susquehanna	Maintain	Neutral	2025-12-19
Morgan Stanley	Upgrade	Overweight	2025-12-16
Mizuho	Maintain	Outperform	2025-09-29
Goldman Sachs	Maintain	Buy	2025-09-26
BMO Capital	Maintain	Market Perform	2025-09-26
Evercore ISI Group	Maintain	Outperform	2025-09-26
TD Cowen	Maintain	Buy	2025-09-26

Genpact Limited Grades

The following table summarizes recent institutional grades for Genpact Limited:

Grading Company	Action	New Grade	Date
Needham	Maintain	Buy	2026-02-06
JP Morgan	Maintain	Neutral	2025-08-20
Needham	Maintain	Buy	2025-08-08
Mizuho	Maintain	Neutral	2025-07-01
Needham	Maintain	Buy	2025-06-30
TD Cowen	Maintain	Buy	2025-06-27
Needham	Maintain	Buy	2025-05-08
Baird	Maintain	Neutral	2025-05-08
Mizuho	Maintain	Neutral	2025-02-10
Needham	Maintain	Buy	2025-02-07

Which company has the best grades?

Accenture exhibits a broader range of grades, including multiple “Outperform” and an “Overweight” upgrade, indicating stronger institutional confidence. Genpact’s grades cluster around “Buy” and “Neutral,” reflecting steadier but less bullish sentiment. This divergence may influence investor perception of growth potential and risk.

Risks specific to each company

The following categories identify the critical pressure points and systemic threats facing both firms in the 2026 market environment:

1. Market & Competition

2. Capital Structure & Debt

3. Stock Volatility

4. Regulatory & Legal

5. Supply Chain & Operations

6. ESG & Climate Transition

7. Geopolitical Exposure

Which company shows a better risk-adjusted profile?

Accenture’s most impactful risk lies in market competition and stock volatility, given its size and beta above 1. Genpact’s primary risk is supply chain and geopolitical exposure due to offshore concentration. Despite higher volatility, Accenture’s robust capital structure and ESG leadership give it a stronger risk-adjusted profile. Genpact’s superior Piotroski score (8 vs. 6) shows financial strength but its operational concentration raises caution. Accenture’s Altman Z-score above 5 confirms its safe zone status, underscoring resilience amid competitive pressures.

Final Verdict: Which stock to choose?

Accenture’s superpower is its unmatched operational efficiency and strong capital allocation, consistently creating value above its cost of capital. Its main point of vigilance lies in a slightly declining ROIC trend, signaling the need to monitor profitability erosion. It fits well in an aggressive growth portfolio seeking industry leaders.

Genpact’s strategic moat stems from its growing ROIC and sustainable competitive advantage, reflected in improving profitability and a robust balance sheet. It offers a safer profile compared to Accenture, with a lower valuation multiple and stronger recent earnings growth. It suits a GARP (Growth at a Reasonable Price) portfolio focused on stable expansion.

If you prioritize operational excellence and industry dominance, Accenture is the compelling choice due to its scale and efficiency. However, if you seek improving profitability with better stability and valuation appeal, Genpact offers a very favorable moat and growth trajectory. Each stock serves distinct investor profiles amid evolving market conditions.

Disclaimer: Investment carries a risk of loss of initial capital. The past performance is not a reliable indicator of future results. Be sure to understand risks before making an investment decision.

Go Further

I encourage you to read the complete analyses of Accenture plc and Genpact Limited to enhance your investment decisions:

• Accenture plc Analysis
• Genpact Limited Analysis